Thus, these results demonstrate that ascitic ATX is a novel diagnostic tool and screening marker to distinguish ovarian cancer from a benign pelvic mass and can enhance the accuracy of methods used to predict high-risk ovarian cancer. The gene discussed is ENPP2; the disease is ovarian cancer.